870243-58-6 Usage
General Description
Methyl thieno[2,3-c]pyridine-2-carboxylate is a chemical compound with a heterocyclic structure that contains a thieno pyridine ring system. It is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and organic materials. This chemical is known for its diverse biological activities, including antitumor, antifungal, and anti-inflammatory properties. Methyl thieno[2,3-c]pyridine-2-carboxylate is also used as a synthetic intermediate in organic chemistry, and its derivatives have shown potential as drug candidates for various diseases. Additionally, it is an important component in the development of new materials and technologies due to its unique structural and functional properties.
Check Digit Verification of cas no
The CAS Registry Mumber 870243-58-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,0,2,4 and 3 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 870243-58:
(8*8)+(7*7)+(6*0)+(5*2)+(4*4)+(3*3)+(2*5)+(1*8)=166
166 % 10 = 6
So 870243-58-6 is a valid CAS Registry Number.
870243-58-6Relevant articles and documents
ALKYL-AND DI-SUBSTITUTED AMIDO-BENZYL SULFONAMIDE DERIVATIVES
-
, (2013/09/12)
The present invention relates to certain alkyl- and di-substituted amido-benzyl sulfonamide compounds, pharmaceutical compositions comprising such compounds, and to methods of treatment of NAMPT-mediated disorders, such as diabetes, rheumatoid arthritis,
PYRIDINYL AND PYRIMIDINYL SULFOXIDE AND SULFONE DERIVATIVES
-
Page/Page column 86; 87, (2013/09/12)
Disclosed are certain pyridinyl and pyrimidinyl sulfoxide and sulfone compounds, pharmaceutical compositions comprising such compounds and methods of treatment using such compounds.
AMIDO-BENZYL SULFOXIDE DERIVATIVES
-
Paragraph 0189, (2013/09/12)
The present invention relates to certain amido-benzyl sulfoxide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment of an NAMPT-mediated disease or condition in a subject, selected from solid or liquid tumor, rheumat
